---
title: "Telomir Pharmaceuticals, Inc. (TELO.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/TELO.US.md"
symbol: "TELO.US"
name: "Telomir Pharmaceuticals, Inc."
industry: "Pharmaceuticals"
datetime: "2026-05-21T16:08:59.878Z"
locales:
  - [en](https://longbridge.com/en/quote/TELO.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/TELO.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/TELO.US.md)
---

# Telomir Pharmaceuticals, Inc. (TELO.US)

## Company Overview

Telomir Pharmaceuticals, Inc., a preclinical-stage biotechnology company, focuses on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases. It is developing Telomir-1, an oral small molecule metal ion regulator designed to protect against age-related conditions, including Wilson’s disease, Type 2 diabetes, age-related macular degeneration (AMD), oncology, and epigenetic regulation, as well as Alzheimer’s disease and Progeria. The company was formerly known as Metallo Therapies Inc. and changed its name to Telomir Pharmaceuticals, Inc.

| Item | Detail |
|------|--------|
| Industry | Pharmaceuticals |
| Exchange | US Market |
| Website | [elomirpharma.com](https://elomirpharma.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -4.88 | 161 | - | - | - |
| PB | 9.08 | 177 | 97.27 | 7.38 | 6.50 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-09-09T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------| 

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 1.27 |
| Highest Target | 15.50 |
| Lowest Target | 15.50 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/TELO.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/TELO.US/norm.md)
- [Related News](https://longbridge.com/en/quote/TELO.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/TELO.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**